ArticleMedicine2026
Incidence of anxiety and depression in epilepsy patients and its correlation with disease control: A retrospective study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This single-center retrospective study explores the incidence of anxiety and depression in epilepsy patients and analyze their correlation with seizure control. A total of 201 epilepsy patients treated at our hospital between February 1, 2022, and February 1, 2024 were included. Based on the Hamilton anxiety rating scale (HAM-A) and self-rating depression scale (SDS) results, patients were divided into an AD group (73 cases) and a NAD group (128 cases). Among the AD group, 45 patients (61.6%) underwent anxiety/depression screening for the first time, highlighting the lack of routine psychological assessment in epilepsy management. Demographic characteristics, epilepsy history, seizure characteristics, medication usage, adherence, seizure control, auxiliary examinations, and psychological interventions were collected. Univariate analysis was performed to screen potential factors, and multivariate logistic regression was subsequently used to identify independent risk factors for anxiety/depression. Patients in the AD group had a younger average age (34.5 ± 12.6 years vs 39.1 ± 11.7 years, P = .047), shorter disease duration (P = .043), higher seizure frequency (P = .034), and poorer seizure control (seizure-free rate 24.7% vs 43.8%, P = .007). Additionally, a higher proportion of patients in this group used 3 or more antiepileptic drugs (17.8% vs 11.7%), and had lower medication adherence (19.2% vs 8.6%, P = .052). Anxiety/depression patients were more likely to receive cognitive behavioral therapy (47.9% vs 32.8%, P = .027), individual psychological counseling (39.7% vs 19.5%, P = .011), and emotional support (43.8% vs 36.7%, P = .039). Multivariate logistic regression analysis suggested that shorter disease duration (OR = 1.82, 95% CI: 1.07-3.11, P = .029), higher seizure frequency (OR = 2.17, 95% CI: 1.12-4.23, P = .021), and low adherence (OR = 2.53, 95% CI: 1.01-6.30, P = .048) were independent risk factors for anxiety/depression. Anxiety and depression are relatively common in epilepsy patients, affecting about 36.3% of them. Emotional disorders are closely related to poor seizure control, lower medication adherence, and complex medication regimens. There is a need to strengthen the assessment and intervention of emotional states in epilepsy patients, especially in those with shorter disease duration and frequent seizures, to promote early identification and management of mental health issues. This can help improve comprehensive treatment outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.